Dominick J Angiolillo Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

11/2022	Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials.
6/2022	Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial.
1/2022	Bleeding avoidance strategies in percutaneous coronary intervention.
12/2021	Severe, Intolerable Fatigue Associated with Hyperresponse to Clopidogrel.
1/2021	Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI.
1/2020	COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial.
12/2019	Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms.
1/2019	Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use.
10/2018	P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes.
12/2016	New oral anticoagulants and dual antiplatelet therapy: Focus on apixaban.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominick J Angiolillo Research Topics

Disease

158	Hemorrhage 12/2022 - 08/2008
121	Acute Coronary Syndrome 11/2022 - 06/2003
102	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 01/2005
96	Thrombosis (Thrombus) 11/2022 - 05/2004
84	Myocardial Infarction 11/2022 - 02/2002
52	Diabetes Mellitus 11/2022 - 07/2006
44	Stroke (Strokes) 11/2022 - 01/2008
36	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 06/2004
27	ST Elevation Myocardial Infarction 10/2022 - 07/2013
18	Type 2 Diabetes Mellitus (MODY) 01/2021 - 08/2005
17	Chronic Renal Insufficiency 11/2022 - 03/2010
17	Atrial Fibrillation 10/2022 - 10/2011
10	Ischemia 01/2022 - 09/2008
10	Death (Near-Death Experience) 11/2021 - 08/2004
9	Unstable Angina 01/2022 - 02/2003
8	Coronary Disease (Coronary Heart Disease) 01/2021 - 08/2005
7	Atherosclerosis 09/2019 - 12/2009
6	Ischemic Stroke 01/2022 - 04/2016
6	Inflammation (Inflammations) 01/2021 - 11/2006
6	Hyperplasia 04/2008 - 08/2004
5	Peripheral Arterial Disease 01/2022 - 09/2007
5	Body Weight (Weight, Body) 01/2020 - 11/2012
4	Neoplasms (Cancer) 01/2022 - 01/2018
4	Vascular Diseases (Vascular Disease) 01/2022 - 02/2014
4	Anemia 11/2021 - 09/2012
4	Infarction (Infarctions) 12/2020 - 07/2013
4	Coronary Stenosis (Coronary Artery Stenosis) 07/2015 - 10/2005
3	Overweight 09/2022 - 04/2004
3	Pain (Aches) 01/2022 - 01/2018
3	Thrombocytopenia (Thrombopenia) 11/2021 - 01/2018
3	Myocardial Ischemia (Ischemic Heart Diseases) 12/2020 - 02/2003
3	AIDS-Related Complex (ARC) 01/2020 - 01/2019
3	Coronary Thrombosis 01/2018 - 01/2004
3	Hypertension (High Blood Pressure) 04/2016 - 09/2007
3	Transient Ischemic Attack 03/2015 - 01/2012
2	Heart Failure 06/2022 - 08/2018
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 10/2019

Drug/Important Bio-Agent (IBA)

140	Clopidogrel (Plavix)FDA Link 06/2022 - 04/2004
119	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2022 - 05/2004
81	TicagrelorIBA 11/2022 - 08/2008
61	Prasugrel Hydrochloride FDA Link 10/2022 - 12/2007
41	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 12/2009
25	AnticoagulantsIBA 11/2022 - 12/2008
23	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2022 - 04/2007
20	Adenosine Diphosphate (ADP)IBA 08/2022 - 01/2007
18	omega-Chloroacetophenone (Mace)IBA 11/2022 - 02/2009
18	Pharmaceutical PreparationsIBA 06/2022 - 10/2007
16	Purinergic P2Y Receptor AntagonistsIBA 01/2022 - 07/2010
16	cangrelorIBA 01/2022 - 08/2008
13	Thrombin FDA Link 09/2022 - 01/2010
8	MetalsIBA 01/2021 - 03/2005
8	vorapaxarIBA 01/2020 - 08/2010
7	TabletsIBA 10/2022 - 05/2016
7	Glycoproteins (Glycoprotein)IBA 05/2014 - 07/2004
6	Vitamin K FDA Link 01/2021 - 12/2016
6	C-Reactive ProteinIBA 01/2021 - 02/2002
6	thienopyridineIBA 04/2017 - 01/2007
6	Sirolimus (Rapamycin)FDA Link 04/2008 - 08/2005
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022 - 06/2010
5	Cytochrome P-450 CYP2C19IBA 01/2022 - 11/2011
5	Tirofiban (Aggrastat)FDA Link 01/2021 - 08/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2011
5	Insulin (Novolin)FDA Link 01/2014 - 07/2006
5	E 5555IBA 07/2012 - 05/2011
4	RivaroxabanIBA 11/2022 - 01/2018
4	Everolimus FDA Link 11/2021 - 01/2020
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2019 - 01/2011
4	Streptokinase FDA Link 01/2018 - 12/2009
4	ThromboxanesIBA 08/2013 - 01/2010
4	Cilostazol (Pletal)FDA LinkGeneric 01/2013 - 09/2008
3	CollagenIBA 08/2022 - 07/2004
3	Dabigatran FDA Link 01/2022 - 03/2016
3	bivalirudin (Angiomax)FDA Link 11/2020 - 09/2016
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019 - 08/2015
3	CSL112IBA 01/2019 - 08/2015
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 12/2009
3	ThienopyridinesIBA 09/2014 - 01/2007
2	insulin receptor-related receptor (IRR)IBA 11/2022 - 03/2022
2	Thromboplastin (Tissue Factor)IBA 09/2022 - 08/2020
2	thrombin receptor peptide SFLLRNPIBA 09/2022 - 08/2022
2	Arachidonic Acid (Vitamin F)IBA 08/2022 - 01/2020
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2021
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 01/2020
2	Fibrinogen (Factor I)FDA Link 01/2021 - 04/2015
2	CobaltIBA 01/2021 - 01/2020
2	ChromiumIBA 01/2021 - 01/2020
2	canakinumab FDA Link 01/2021 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 10/2020 - 05/2018

Therapy/Procedure

173	Therapeutics 11/2022 - 07/2006
144	Percutaneous Coronary Intervention 11/2022 - 01/2006
92	Stents 11/2022 - 05/2004
20	Drug-Eluting Stents 03/2022 - 03/2005
15	Secondary Prevention 01/2021 - 01/2010
7	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 02/2008
4	Drug Therapy (Chemotherapy) 01/2017 - 01/2012
3	Brachytherapy 08/2005 - 05/2004
2	Duration of Therapy 01/2022 - 12/2011
2	Oral Administration 01/2021 - 10/2011
2	Intravenous Administration 01/2021 - 01/2019
2	Transcatheter Aortic Valve Replacement 01/2021 - 10/2019